Cancer treatment in India is becoming more affordable as cheaper versions of the key drug Nivolumab enter the market, making immunotherapy accessible to more patients.This price reduction, along with potential lower dosage research, is significantly improving access to modern cancer care. Cancer treatment in India may soon become more affordable for thousands of patients It has been observed that over the past six months doctors have started prescribing immunotherapy to more cancer.